Author Page for Chao-Pin Yang

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Neoadjuvant Toripalimab with Chemotherapy is Feasible for Resectable Stage III Non-Small-Cell Lung Cancer: A Single-Arm, Phase 2 Trial

Number of pages: 30 Posted: 12 May 2021

Ze-Rui Zhao, Chao-Pin Yang, Si Chen, Yong-Bin Lin, Yao-Bin Lin, Han Qi, Jietian Jin, Shan-Shan Lian, Yi-Zhi Wang, Wen-Yu Zhai and Hui Yu

Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-Sen University (SYSU) - Department of Biotherapy, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Department of Radiology, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China

Downloads 50 (1,063,489)

Citation 1

Chao-Pin Yang

Sun Yat-Sen University (SYSU) - Department of Biotherapy

1

50

1

Scholarly Papers (1)

Neoadjuvant Toripalimab with Chemotherapy is Feasible for Resectable Stage III Non-Small-Cell Lung Cancer: A Single-Arm, Phase 2 Trial

Abstract: